UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Percutaneous Lung Biopsy: Point-Fine-Needle Aspiration First

American journal of roentgenology (1976), 2022-05, Vol.218 (5), p.794-795

VanderLaan, Paul A

2022

Volltextzugriff (PDF)

Fine‐needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities

Cancer cytopathology, 2016-12, Vol.124 (12), p.862-870

VanderLaan, Paul A.

2016

Volltextzugriff (PDF)

The 2023 Bethesda System for Reporting Thyroid Cytopathology

Thyroid (New York, N.Y.), 2023-09, Vol.33 (9), p.1039

2023

Volltextzugriff (PDF)

The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

Third edition, 2023

Volltextzugriff (PDF)

Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations: Should Repeated FNA Be the Preferred Initial Approach?

American journal of clinical pathology, 2011-05, Vol.135 (5), p.770-775

2011

Volltextzugriff (PDF)

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma

Journal of thoracic oncology, 2017-05, Vol.12 (5), p.878-883

2017

Volltextzugriff (PDF)

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Lung cancer (Amsterdam, Netherlands), 2015-04, Vol.88 (1), p.108-111

2015

Volltextzugriff (PDF)

The role of the cytopathology journal in the days of digital media

Journal of the American Society of Cytopathology JASC, 2023-01, Vol.12 (1), p.1-2

VanderLaan, Paul A.

2023

Volltextzugriff (PDF)

EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.1995-2002

2019

Volltextzugriff (PDF)

Lung Cancer with a High Tumor Mutational Burden

The New England journal of medicine, 2018-09, Vol.379 (11), p.1093

2018

Volltextzugriff (PDF)

Non–small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

Cancer cytopathology, 2019-05, Vol.127 (5), p.278-280

VanderLaan, Paul A.

2019

Volltextzugriff (PDF)

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: correlation with clinical outcomes

Lung cancer (Amsterdam, Netherlands), 2017-04, Vol.106, p.17-21

2017

Volltextzugriff (PDF)

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Nature communications, 2015-03, Vol.6 (1), p.6377-6377, Article 6377

2015

Volltextzugriff (PDF)

Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size

Journal of thoracic oncology, 2017-08, Vol.12 (8), p.1288-1298

2017

Volltextzugriff (PDF)

Molecular markers: Implications for cytopathology and specimen collection

Cancer cytopathology, 2015-08, Vol.123 (8), p.454-460

VanderLaan, Paul A.

2015

Volltextzugriff (PDF)

Rapid examination of lung tissues by nonlinear microscopy

American journal of clinical pathology, 2024-10, Vol.162 (4), p.369-378

2024

Volltextzugriff (PDF)

CT Manifestations of Tumor Spread Through Airspaces in Pulmonary Adenocarcinomas Presenting as Subsolid Nodules

Journal of thoracic imaging, 2018-11, Vol.33 (6), p.402-408

2018

Volltextzugriff (PDF)

Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance

Cancer cytopathology, 2023-05, Vol.131 (5), p.313-324

2023

Volltextzugriff (PDF)

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer

Clinical cancer research, 2018-12, Vol.24 (23), p.5963-5976

2018

Volltextzugriff (PDF)

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT

Radiology, 2020-10, Vol.297 (1), p.189-198

2020

Volltextzugriff (PDF)

CT Manifestations of Tumor Spread through Air Spaces in Lung Adenocarcinoma: Different Pathways toward Common Perspectives

Radiology, 2019-01, Vol.290 (1), p.271-272

2019

Volltextzugriff (PDF)

Current and future trends in non–small cell lung cancer biomarker testing: The American experience

Cancer cytopathology, 2020-09, Vol.128 (9), p.629-636

2020

Volltextzugriff (PDF)

Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance

American journal of clinical pathology, 2011-10, Vol.136 (4), p.572-577

2011

Volltextzugriff (PDF)

Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies

Archives of pathology & laboratory medicine (1976), 2020-08, Vol.144 (8), p.933-958

2020

Volltextzugriff (PDF)

The rapidly evolving landscape of biomarker testing in non–small cell lung cancer

Cancer cytopathology, 2021-03, Vol.129 (3), p.179-181

2021

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(306)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(334)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Percutaneous Lung Biopsy: Point-Fine-Needle Aspiration First

Fine‐needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities

The 2023 Bethesda System for Reporting Thyroid Cytopathology

The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes

Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations: Should Repeated FNA Be the Preferred Initial Approach?

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

The role of the cytopathology journal in the days of digital media

EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples

Lung Cancer with a High Tumor Mutational Burden

Non–small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: correlation with clinical outcomes

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size

Molecular markers: Implications for cytopathology and specimen collection

Rapid examination of lung tissues by nonlinear microscopy

CT Manifestations of Tumor Spread Through Airspaces in Pulmonary Adenocarcinomas Presenting as Subsolid Nodules

Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT

CT Manifestations of Tumor Spread through Air Spaces in Lung Adenocarcinoma: Different Pathways toward Common Perspectives

Current and future trends in non–small cell lung cancer biomarker testing: The American experience

Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance

Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies

The rapidly evolving landscape of biomarker testing in non–small cell lung cancer

Suchergebnisse filtern